About
Nick Traggis is a biotech and diagnostics operator based in Boulder, Colorado. He is the founder and chief executive officer of Ambrosia Biosciences, a drug discovery company developing oral small-molecule therapies for obesity and other metabolic disorders. Earlier, he became CEO of LightDeck Diagnostics after serving as EVP of corporate development, and previously worked with Chris Myatt at Precision Photonics.
Areas of interest
biotechdrug discoverycardiometabolic therapiesobesitymetabolic disordersGLP-1small moleculesdiagnostics